StonvexLoading…
StonvexStonvexStonvexCore line items from DRH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $319.00M | $258.16M | $1.12B | $845.96M | $560.57M |
Operating Income | Not available | $14.58M | $100.71M | $76.21M | $53.10M |
Net Income | Not available | $14.46M | $101.43M | $75.22M | $52.69M |
EPS (Diluted) | $0.22 | $0.07 | $0.44 | $0.33 | $0.23 |
Total Assets | Not available | $3.01B | $3.00B | $3.15B | $3.06B |
Total Liabilities | Not available | $1.56B | $1.55B | $1.57B | $1.48B |
Cash & Equivalents | Not available | $39.29M | $68.08M | $145.34M | $52.40M |
Free Cash Flow OCF − CapEx | Not available | $1.13M | $162.09M | $114.79M | $59.90M |
Shares Outstanding | Not available | 204.62M | 203.70M | 203.90M | 205.38M |